#1 Clinical Trials Search in Europe

Moxifloxacin Hydrochloride

Moxifloxacin hydrochloride is an antibiotic medication that has been studied in various clinical trials for different medical conditions. This article examines how moxifloxacin has been used and evaluated in clinical research, looking at its potential benefits and effects across several areas of medicine, from treating infections to its impact on heart function.

Table of Contents

What is Moxifloxacin Hydrochloride?

Moxifloxacin Hydrochloride is an antibiotic medication that belongs to a class of drugs called fluoroquinolones. It is also known by brand names such as Avelox, Vigamox, and Moxeza[1]. This medication works by killing bacteria or preventing their growth, making it effective against a wide range of infections[2].

Uses of Moxifloxacin

Moxifloxacin is used to treat various bacterial infections in different parts of the body. Some of its common uses include:

  • Eye infections: It is used as an eye drop to prevent and treat bacterial eye infections, particularly before and after eye surgeries like cataract removal[3].
  • Respiratory infections: Moxifloxacin is effective against respiratory tract infections, including those associated with chronic obstructive pulmonary disease (COPD)[4].
  • Periodontal (gum) infections: It can be used in gel form to treat infections in periodontal pockets, which are spaces between the gums and teeth[2].
  • Prevention of infections in cancer patients: Moxifloxacin may be used to prevent bacterial infections in patients who have undergone stem cell transplants and have weakened immune systems[5].

How Moxifloxacin is Administered

Moxifloxacin can be administered in several ways, depending on the condition being treated:

  • Oral tablets: For systemic infections, moxifloxacin is often given as a 400 mg tablet taken once daily[6].
  • Eye drops: For eye infections or prevention before and after eye surgery, moxifloxacin is used as an eye drop, typically administered several times a day[3].
  • Dental gel: For periodontal infections, a special gel form may be applied directly into the periodontal pockets[2].
  • Injection: In some cases, particularly for preventing infections after eye surgery, moxifloxacin may be injected directly into the eye during the procedure[7].

Effectiveness of Moxifloxacin

Moxifloxacin has shown effectiveness in treating various bacterial infections. For example:

  • In eye surgeries, it has been found to be effective in preventing post-operative infections when used as a prophylactic (preventive) treatment[3].
  • For respiratory infections, particularly in COPD patients, moxifloxacin has demonstrated efficacy in treating acute exacerbations (sudden worsening of symptoms)[4].
  • In periodontal treatments, moxifloxacin gel has shown promise as an adjunct (additional) therapy to standard treatments like scaling and root planing[2].

Safety and Side Effects

While moxifloxacin is generally considered safe when used as directed, it can cause side effects. Some potential side effects include:

  • Gastrointestinal issues like nausea or diarrhea
  • Headache
  • Dizziness
  • Changes in heart rhythm (rare but serious)

It’s important to note that the safety profile may vary depending on how the drug is administered. For example, when used as an eye drop, the systemic (whole-body) absorption is minimal, which can reduce the risk of systemic side effects[8].

Ongoing Research

Researchers continue to study moxifloxacin to better understand its effects and potential new uses. Some areas of ongoing research include:

  • Cancer treatment: There is interest in whether moxifloxacin could enhance the effects of standard cancer treatments in advanced breast cancer[6].
  • Blood glucose effects: Studies are investigating whether moxifloxacin affects blood glucose levels in people without diabetes[9].
  • Heart effects: Researchers are studying the effects of moxifloxacin on heart rhythm, which is important for understanding its safety profile[10].

It’s important to remember that while these research areas are promising, more studies are needed before any new uses for moxifloxacin can be approved. Always use moxifloxacin as directed by your healthcare provider and report any unusual side effects promptly.

Condition/Use Study Type Moxifloxacin Dosage Key Findings/Objectives
Acute Exacerbation of COPD Randomized, Open-Label 400 mg oral tablet daily Compared to sitafloxacin for efficacy and safety
Prevention of Bacterial Infections in Stem Cell Transplant Randomized, Double-Blind, Placebo-Controlled 400 mg oral tablet daily Assessed efficacy in reducing bacterial infections post-transplant
Cataract Surgery Prophylaxis Open-Label, Randomized 0.5% ophthalmic solution Compared to besifloxacin and gatifloxacin for safety and efficacy
Cardiac Repolarization Effects Randomized, Double-Blind, Placebo-Controlled 400 mg oral tablet Used as positive control to evaluate effects on QT interval

FAQ

  • What conditions has moxifloxacin hydrochloride been studied for in clinical trials? Moxifloxacin hydrochloride has been studied for various conditions including acute exacerbation of chronic obstructive pulmonary disease (COPD), prevention of bacterial infections in stem cell transplant patients, and as a prophylactic treatment before and after cataract surgery.
  • How is moxifloxacin typically administered in clinical trials? In the trials reviewed, moxifloxacin was administered in different ways depending on the study. It was given orally as 400 mg tablets, as eye drops for ophthalmic use, and in some cases as part of a combination therapy.
  • What are some of the potential benefits of moxifloxacin observed in clinical trials? Some potential benefits observed include its effectiveness in treating acute COPD exacerbations, preventing bacterial infections in immunocompromised patients, and its use as a prophylactic antibiotic in eye surgery to prevent post-operative infections.
  • Are there any side effects or safety concerns associated with moxifloxacin in clinical trials? While specific side effects weren't detailed in the provided trial summaries, safety and tolerability were often mentioned as study outcomes. In some trials, moxifloxacin was used as a 'positive control', suggesting its effects are well-known and can be used as a comparison for other drugs.
  • How does moxifloxacin compare to other antibiotics in clinical trials? In some trials, moxifloxacin was compared to other antibiotics like sitafloxacin, besifloxacin, and gatifloxacin. These comparisons help researchers understand the relative effectiveness and safety of moxifloxacin in different clinical scenarios.

Ongoing Clinical Trials on Moxifloxacin Hydrochloride

  • Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study on the Effectiveness of Clarithromycin and Other Drug Combinations for Patients with Uncomplicated Staphylococcus aureus Blood Infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    Denmark

  • Study Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection

    Recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • Study on Oral Antibiotics Moxifloxacin, Linezolid, and Metronidazole for Patients with Bacterial Brain Abscess

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France The Netherlands Sweden

  • Study of antibiotic combination therapy duration based on patient response for adults with community-acquired pneumonia

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of High-Dose Rifampicin, Moxifloxacin, and Linezolid for Patients with Pulmonary Tuberculosis

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Chronic Obstructive Pulmonary Disease (COPD): A group of lung diseases that block airflow and make it difficult to breathe. It includes emphysema and chronic bronchitis.
  • Acute Exacerbation: A sudden worsening of symptoms in a chronic condition, such as COPD, often requiring additional treatment.
  • Allogeneic Stem Cell Transplantation: A procedure where a person receives blood-forming stem cells from a genetically similar, but not identical, donor.
  • Prophylaxis: Preventive treatment to stop a disease from occurring.
  • Endophthalmitis: An inflammation of the internal coats of the eye, which can be a serious complication after eye surgery.
  • Macular Edema: Swelling or thickening of the macula, the part of the eye responsible for detailed central vision.
  • Phacoemulsification: A modern cataract surgery technique that uses ultrasound energy to break up the lens before it is removed.
  • Intraocular Lens (IOL): An artificial lens implanted in the eye to replace the natural lens during cataract surgery.
  • Aqueous Humor: The clear, watery fluid in the front part of the eye between the cornea and the lens.
  • QT Interval: A measurement on an electrocardiogram that represents the time it takes for the heart's electrical system to fire an impulse and then recharge.
  • Cardiac Repolarization: The process where the heart muscle relaxes after each heartbeat, preparing for the next contraction.

References

  1. https://clinicaltrials.gov/study/NCT00824070
  2. https://clinicaltrials.gov/study/NCT02016157
  3. https://clinicaltrials.gov/study/NCT01455233
  4. https://clinicaltrials.gov/study/NCT05400369
  5. https://clinicaltrials.gov/study/NCT00324324
  6. https://clinicaltrials.gov/study/NCT03405168
  7. https://clinicaltrials.gov/study/NCT05079854
  8. https://clinicaltrials.gov/study/NCT02515045
  9. https://clinicaltrials.gov/study/NCT04692623
  10. https://clinicaltrials.gov/study/NCT03162900